Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations

Antonino Di Caro; Flavia Cunha; Nicola Petrosillo; Nicholas J Beeching; Oner Ergonul; Eskild Petersen; Marion P G Koopmans

doi:10.1016/j.cmi.2021.03.011

Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations

Clin Microbiol Infect. 2021 Jun;27(6):823-826. doi: 10.1016/j.cmi.2021.03.011. Epub 2021 Mar 29.

Authors

Antonino Di Caro¹, Flavia Cunha², Nicola Petrosillo³, Nicholas J Beeching⁴, Oner Ergonul⁵, Eskild Petersen⁶, Marion P G Koopmans⁷

Affiliations

¹ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Laboratory of Microbiology, National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy; Department of Molecular Medicine, San Matteo Hospital, University of Pavia, Pavia, Italy.
² European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Department of Infectious Diseases, Coimbra Hospital and University Centre, Coimbra, Portugal.
³ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), International Affairs Subcommittee, Basel, Switzerland; Clinical and Research Department, National Institute for Infectious Diseases 'Lazzaro Pallanzani', Rome, Italy.
⁴ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Tropical and Infectious Disease Unit, Royal Liverpool University Hospital, Liverpool School of Tropical Medicine, Liverpool, UK.
⁵ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Koç University Research Centre for Infectious Diseases, Istanbul, Turkey.
⁶ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark. Electronic address: eskild.petersen@gmail.com.
⁷ European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Viroscience Department, ErasmusMC, WHO Collaborating Centre, Rotterdam, the Netherlands.

No abstract available

Keywords: Coronavirus disease 2019; Escape mutants; Immunity; Severe acute respiratory syndrome coronavirus 2; Vaccine.

Publication types

Review

MeSH terms

COVID-19 / virology*
COVID-19 Vaccines / immunology*
Humans
Mutation*
SARS-CoV-2 / genetics*
SARS-CoV-2 / immunology
Vaccination*

Substances

COVID-19 Vaccines